EUIPOProtect this trademark from copycats!
With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.
The Union trademark OBAINZY was filed as Word mark on 04/18/2024 at the European Union Intellectual Property Office. The current status of the mark is "Application published".
| Trademark form | Word mark |
| File reference | 019015879 |
| Application date | April 18, 2024 |
| Publication date | May 16, 2024 |
Trademark owner
5th Floor 50 Broadway
SW1H 0BL London
GB
SW1H 0BL London
GB
Trademark representatives
Avda. de Europa, 26
Edif. ÁTICA 5, Planta 2
28224 Pozuelo de Alarcón (MADRID)
ES
goods and services
5
Pharmaceutical preparations and substances for the treatment of osteoporosis; pharmaceutical preparations and substances for the alleviation of osteoporosis-related symptoms; pharmaceutical preparations and substances for the treatment of cartilage disorders; pharmaceutical preparations and substances for the treatment of bone disorders; pharmaceutical preparations and substances for the treatment of bone loss; pharmaceutical preparations and substances for the alleviation of bone-loss related symptoms; pharmaceutical preparations and substances for the treatment of osteoporosis in postmenopausal women and in men at increased risk of fractures; pharmaceutical preparations and substances for the treatment of bone loss associated with hormone ablation in men with prostate cancer at increased risk of fractures; pharmaceutical preparations and substances for the treatment of bone loss associated with long-term systemic glucocorticoid therapy in adult patients at increased risk of fracture; pharmaceutical preparations for the treatment of menopause; pharmaceutical preparations and substances for the alleviation of menopause-related symptoms; pharmaceutical preparations and substances for use in relation to women’s health; pharmaceutical preparations and substances for use in rheumatology; pharmaceutical preparations and substances for the treatment of arthritis; pharmaceutical preparations and substances for the treatment of rheumatoid arthritis; pharmaceutical preparations and substances for the treatment of juvenile idiopathic polyarthritis; pharmaceutical preparations and substances for the treatment of active systemic juvenile idiopathic arthritis; pharmaceutical preparations and substances for use in endocrinology; pharmaceutical preparations and substances for use in the treatment of respiratory conditions; pharmaceutical preparations and substances for use in the treatment of coronavirus disease; pharmaceutical preparations and substances for use in the treatment of cytokine release syndrome; all the above being for human use
ID: 11019015879